Tradewinds Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-120
Closed -$21K 750
2020
Q1
$21K Sell
120
-375
-76% -$70.6K 0.01% 252
2019
Q4
$95K Buy
495
+475
+2,375% +$85.7K 0.03% 146
2019
Q3
$3K Hold
20
﹤0.01% 517
2019
Q2
$3K Hold
20
﹤0.01% 519
2019
Q1
$3K Hold
20
﹤0.01% 523
2018
Q4
$3K Sell
20
-33
-62% -$5.41K ﹤0.01% 540
2018
Q3
$10K Hold
53
﹤0.01% 420
2018
Q2
$9K Hold
53
﹤0.01% 429
2018
Q1
$9K Buy
53
+20
+61% +$3.35K ﹤0.01% 420
2017
Q4
$5K Buy
+33
New +$5.92K ﹤0.01% 518
2016
Q2
Sell
-13
Closed -$3K 689
2016
Q1
$3K Hold
13
﹤0.01% 536
2015
Q4
$4K Hold
13
﹤0.01% 483
2015
Q3
$4K Hold
13
﹤0.01% 471
2015
Q2
$4K Hold
13
﹤0.01% 516
2015
Q1
$4K Buy
+13
New +$3.71K ﹤0.01% 478

Other funds holding AGN

Tradewinds Capital Management's AGN Position: Q2 2020 in Review

Tradewinds Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 120 shares — an estimated $21K sold.

Tradewinds Capital Management first reported a position in AGN in Q1 2015 and held it in 15 quarters. The position peaked at $95K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Tradewinds Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Tradewinds Capital Management sold 120 Allergan plc shares in Q2 2020, an estimated $21K.
  • Tradewinds Capital Management first reported a position in Allergan plc in Q1 2015 and held it in 15 quarters.
  • Tradewinds Capital Management's Allergan plc position peaked at $95K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Tradewinds Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.